PL345334A1 - Poly(adp-ribose)polymerase gene - Google Patents

Poly(adp-ribose)polymerase gene

Info

Publication number
PL345334A1
PL345334A1 PL99345334A PL34533499A PL345334A1 PL 345334 A1 PL345334 A1 PL 345334A1 PL 99345334 A PL99345334 A PL 99345334A PL 34533499 A PL34533499 A PL 34533499A PL 345334 A1 PL345334 A1 PL 345334A1
Authority
PL
Poland
Prior art keywords
adp
ribose
poly
polymerase gene
polymerase
Prior art date
Application number
PL99345334A
Other languages
English (en)
Inventor
Michael Kock
Thomas Hoeger
Burkhard Kroeger
Bernd Otterbach
Hans-Georg Lemaire
Wilfried Lubisch
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of PL345334A1 publication Critical patent/PL345334A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/02—Pentosyltransferases (2.4.2)
    • C12Y204/0203—NAD+ ADP-ribosyltransferase (2.4.2.30), i.e. tankyrase or poly(ADP-ribose) polymerase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91091—Glycosyltransferases (2.4)
    • G01N2333/91142—Pentosyltransferases (2.4.2)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
PL99345334A 1998-06-05 1999-06-04 Poly(adp-ribose)polymerase gene PL345334A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19825213 1998-06-05
DE19908837 1999-03-01

Publications (1)

Publication Number Publication Date
PL345334A1 true PL345334A1 (en) 2001-12-17

Family

ID=26046644

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99345334A PL345334A1 (en) 1998-06-05 1999-06-04 Poly(adp-ribose)polymerase gene

Country Status (24)

Country Link
US (3) US7754459B1 (de)
EP (1) EP1082416B1 (de)
JP (1) JP2002517231A (de)
KR (1) KR20010052582A (de)
CN (1) CN1304446A (de)
AR (1) AR020326A1 (de)
AT (1) ATE358175T1 (de)
AU (1) AU4605999A (de)
BG (1) BG105018A (de)
BR (1) BR9910967A (de)
CA (1) CA2330206C (de)
CO (1) CO5070700A1 (de)
DE (1) DE59914280D1 (de)
ES (1) ES2285842T3 (de)
HK (1) HK1038591A1 (de)
HR (1) HRP20010013A2 (de)
HU (1) HUP0103190A2 (de)
ID (1) ID27819A (de)
IL (1) IL139750A0 (de)
NO (1) NO20006153L (de)
PL (1) PL345334A1 (de)
SK (1) SK17892000A3 (de)
TR (1) TR200003624T2 (de)
WO (1) WO1999064572A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19921567A1 (de) 1999-05-11 2000-11-16 Basf Ag Verwendung von Phthalazine-Derivaten
CN1370238A (zh) * 1999-06-16 2002-09-18 艾科斯有限公司 人聚(adp-核酸)聚合酶2的物质和方法
ES2290115T3 (es) 2000-02-01 2008-02-16 ABBOTT GMBH & CO. KG Compuestos heterociclicos y su aplicacion como inhibidores de parp.
EP1906948A4 (de) 2005-07-18 2010-03-17 Bipar Sciences Inc Krebsbehandlung
WO2008030883A2 (en) 2006-09-05 2008-03-13 Bipar Sciences, Inc. Treatment of cancer
AU2007292306A1 (en) 2006-09-05 2008-03-13 Bipar Sciences, Inc. Inhibition of fatty acid synthesis by PARP inhibitors and methods of treatment thereof
WO2009064738A2 (en) 2007-11-12 2009-05-22 Bipar Sciences, Inc. Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents
GB201102865D0 (en) 2011-02-18 2011-04-06 Danisco Feed additive composition
GB201102857D0 (en) 2011-02-18 2011-04-06 Danisco Feed additive composition
US20130330308A1 (en) 2011-02-18 2013-12-12 Dupont Nutrition Biosciences Aps Feed additive composition
GB201213801D0 (en) 2012-08-03 2012-09-12 Dupont Nutrition Biosci Aps Feed additive composition
EP2890780B8 (de) 2012-08-29 2020-08-19 Sangamo Therapeutics, Inc. Verfahren und zusammensetzungen zur behandlung eines genetischen leidens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162508A (en) 1987-12-18 1992-11-10 Compagnie Oris Industrie Rare earth cryptates, processes for their preparation, synthesis intermediates and application as fluorescent tracers
US5272057A (en) * 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
FR2707011A1 (en) 1993-06-25 1994-12-30 Pasteur Sanofi Diagnostics Immunological process for the detection and assay of antibodies directed against poly(ADP-ribose) polymerase, application to diagnosis, kit for its implementation
DE4444949C1 (de) 1994-12-16 1996-11-21 Deutsches Krebsforsch Vektoren und Viren zur Gentherapie

Also Published As

Publication number Publication date
US7754459B1 (en) 2010-07-13
BG105018A (en) 2001-12-31
CA2330206A1 (en) 1999-12-16
KR20010052582A (ko) 2001-06-25
WO1999064572A2 (de) 1999-12-16
ID27819A (id) 2001-04-26
AU4605999A (en) 1999-12-30
US9051553B2 (en) 2015-06-09
JP2002517231A (ja) 2002-06-18
US20160010067A1 (en) 2016-01-14
ES2285842T3 (es) 2007-11-16
SK17892000A3 (sk) 2001-09-11
DE59914280D1 (en) 2007-05-10
ATE358175T1 (de) 2007-04-15
CA2330206C (en) 2010-04-13
AR020326A1 (es) 2002-05-08
HRP20010013A2 (en) 2001-12-31
IL139750A0 (en) 2002-02-10
WO1999064572A3 (de) 2000-06-08
BR9910967A (pt) 2001-02-13
HUP0103190A2 (hu) 2001-12-28
NO20006153D0 (no) 2000-12-04
HK1038591A1 (zh) 2002-03-22
CN1304446A (zh) 2001-07-18
EP1082416A2 (de) 2001-03-14
NO20006153L (no) 2001-02-02
CO5070700A1 (es) 2001-08-28
TR200003624T2 (tr) 2001-06-21
US20110107444A1 (en) 2011-05-05
EP1082416B1 (de) 2007-03-28

Similar Documents

Publication Publication Date Title
AU4680599A (en) Thermostable polymerase
ZA9811939B (en) Novel macrolides.
IL138584A0 (en) Dihydropyrimidines
HUP0201438A3 (en) Dna vaccine - pcv
AU3572799A (en) Function-based gene discovery
IL139750A0 (en) Poly (adp-ribose) polymerase gene
IL140884A0 (en) Novel dna cleaving antitumor agents
ZA992322B (en) Phosphodiesterase iv-inhibiting diazepinoindoles.
AU3849999A (en) Endo-beta-n-acetylglucosaminidase gene
IL142895A0 (en) Adenine nucleotide translocator polyptides
DE69833112D1 (en) Rna polymerase
GB9817704D0 (en) Gene switch
HUP0105208A3 (en) Gene therapy-1
IL146332A0 (en) PrP-LIKE GENE
GB2344591B (en) Thermostable DNA polymerase
GB9905644D0 (en) Dna
AU4513599A (en) Nucleotide sequence
EP1080100A4 (de) Cytosindeaminase-gen
EP1086244A4 (de) Methode zur erkennung der gene von restriktionsenzymen
GB9724828D0 (en) Gene
GB9809753D0 (en) Gene
GB9818734D0 (en) Gene
GB9822216D0 (en) Gene transfer
GB9819721D0 (en) Novel gene
GB9806702D0 (en) Dna

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)